Brain hypometabolism and cognitive impairment in long COVID: Insights from [18F]FDG-PET-CT imaging and neurocognitive assessment
Medicina Clínica · 2025
DOI: 10.1016/j.medcli.2025.107140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina Clínica, 2025. Verfasst von Manuel De Miguel-Escribano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Medicina Interna, Unidad de Enfermedades Autoinmunes y Minoritarias, Hospital Universitario Virgen del Rocío, Sevilla, Spain. Electronic …. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, COVID-19, Cognitive Dysfunction, Brain. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Despite the progressive socioeconomic and healthcare recovery following the SARS-CoV-2 pandemic, its sequelae remain markedly evident today. Among them, Long COVID significantly impairs patient functionality and quality of life. Neurocognitive impairment stands out as one of its most debilitating manifestations. PATIENTS AND METHODS: We assessed 16 patients diagnosed with Long COVID and neurocognitive dysfunction, quantifying the degree of impairment using cognitive evaluation tests and comparing these results with findings from prior [18F]FDG-PET-CT brain scans. RESULTS: The mean cognitive test scores demonstrated significant impairment. Patients predominantly exhibited mild hypometabolism across various regions, with the cerebellum identified as the most frequently affected area. Those with more pronounced [18F]FDG-PET-CT abnormalities exhibited greater cognitive deficits. Greater hypometabolism and thalamic involvement were associated with lower cognitive assessment score. CONCLUSION: We support the role of cerebral hypometabolism in the development of neurocognitive impairment associated with Long COVID, although its underlying pathophysiological mechanisms remain to be elucidated. We further endorse the potential link between cerebellar hypometabolism and cognitive decline. Greater severity in brain [18F]FDG-PET-CT abnormalities and thalamic dysfunction may correlate worse cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Medicina Interna, Unidad de Enfermedades Autoinmunes y Minoritarias, Hospital Universitario Virgen del Rocío, Sevilla, Spain. Electronic address: mdemiguelescribano@gmail.com.
- Servicio de Medicina Interna, Unidad de Enfermedades Autoinmunes y Minoritarias, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Zitieren
APA
De Miguel-Escribano, M., Martín-Garrido, I., Garrido-Montes, M., Pertusa-Mataix, R., Corchero-Gijón, J., & Morillo, J. S. G. (2025). Brain hypometabolism and cognitive impairment in long COVID: Insights from [18F]FDG-PET-CT imaging and neurocognitive assessment. Medicina Clínica. https://doi.org/10.1016/j.medcli.2025.107140
Vancouver
De Miguel-Escribano M, Martín-Garrido I, Garrido-Montes M, Pertusa-Mataix R, Corchero-Gijón J, Morillo JSG. Brain hypometabolism and cognitive impairment in long COVID: Insights from [18F]FDG-PET-CT imaging and neurocognitive assessment. Medicina Clínica. 2025. doi:10.1016/j.medcli.2025.107140
BibTeX
@article{DeMiguelEscribano2025,
author = {De Miguel-Escribano, Manuel and Martín-Garrido, Isabel and Garrido-Montes, Manuel and Pertusa-Mataix, Roberto and Corchero-Gijón, Jorge and Morillo, José Salvador García},
title = {Brain hypometabolism and cognitive impairment in long COVID: Insights from [18F]FDG-PET-CT imaging and neurocognitive assessment},
journal = {Medicina Clínica},
year = {2025},
doi = {10.1016/j.medcli.2025.107140}
}
EUVIMED